Presentation Resources
Mattson, C. L., Tanz, L. J., Quinn, K., Kariisa, M., Patel, P., & Davis, N. L. (2021). Trends and geographic patterns in drug and synthetic opioid overdose deaths— United States, 2013–2019. Morbidity and Mortality Weekly Report, 70(6), 2021. ///
https://www.cdc.gov/mmwr/volumes/70/wr/mm7006a4.htm
• Moos, R. H. (2008). Active ingredients of substance use-focused self-help groups. Addiction, 103(3), 387-396. ////
Abstract only at https://pubmed.ncbi.nlm.nih.gov/18269361/
• Abrahamsson T, Berge J, Ojehagen A, et al. Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-–a nation-wide register-based open cohort study. Drug Alcohol Depend 2017;
http://dx.doi.org/doi:10.1016/j.drugalcdep.2017.01.013
• Chan YY, Chen YH, Yang SN, et al. Clinical efficacy of traditional Chinese medicine, suan zao ren tang, for sleep disturbance during methadone maintenance: a randomized, double-blind, placebo-controlled trial. Evid Based Complement Alternat Med 2015; 2015:710895. doi:10.1155/2015/710895. Epub 2015 Aug 4
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539464/
• Dean AJ, Bell J, Christie MJ, et al. Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence. European Psychiatry 2004;19:510-513
https://doi.org/10.1177%2F07067437221145013
• Fava M, Memisoglu A, Thase ME, et al. Opioid modulation with buprenorphine/samidorphan as adjunctive treatment for inadequate response to antidepressants: a randomized double-blind placebo-controlled trial. Am J Psychiatry 2016;173:499-508 https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2015.15070921?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
• Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, and disability of personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2004;65:948-958. Abstract only at https://pubmed.ncbi.nlm.nih.gov/15291684/
• Grant BF, Saha TD, Ruan WJ, et al. Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Jama Psychiatry 2016;73(1):39-47. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062605/
• Grella CE, Karno MP, Warda US, et al. Gender and comorbidity among individuals with opioid use disorders in the NESARC study. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708101/
• Hasin DS, Grant BF. The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) waves 1 and 2: review and summary of findings. Soc Psychiatry Psychiatr Epidemiol 2015;50:1609-1640.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618096/
• Hedges DW, Brown BL, Shwalb DA, et al. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials. J Psychopharmacol 2007;21:102-111.
Abstract only at https://pubmed.ncbi.nlm.nih.gov/16714326/
• Huhn M, Tardy M, Spineli LM, et al. Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic review and meta-analysis. JAMA Psychiatry 2014;71:706-715. Abstract only at https://jamanetwork.com/journals/jamapsychiatry/article-abstract/1865002
• Krupitsky E, Zvartau E, Blokhina E, et al. Anhedonia, depression, anxiety, and craving in opiate dependent patients stabilized on oral naltrexone or an extended release naltrexone implant. Am J Drug Alcohol Abuse 2016;42:614-620
• Li Y, Liu XB, Zhang Y. Acupuncture therapy for the improvement of sleep quality of outpatients receiving methadone maintenance treatment: a randomized controlled trial. Zhongguo Zhong Xi Yi Jie He Za Zhi 2012;32:1056-1069.
Abstract only at https://pubmed.ncbi.nlm.nih.gov/23173252/
• Martins SS, Keyes KM, Storr CL, et al. Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Dep 2009;103:16-24. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699563/
• Mills KL, Lynskey M, Teesson M, et al. Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): prevalence and correlates. Drug Alcohol Dep 2005;77:243-249.
https://pubmed.ncbi.nlm.nih.gov/15734224/
• Nunes EV, Sullivan MA, Levin FR. Treatment of depression in patients with opiate dependence. Biol Psychiatry 2004;56:793-802. https://pubmed.ncbi.nlm.nih.gov/15556125/
• Park TW, Saitz R, Ganoczy D, et al. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ 2015;350: h2698. doi: 10.1136/bmj.h2698.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462713/
• Peirce JM, Brooner RK, King VL, et al. Effect of traumatic event re-exposure and PTSD on substance abuse disorder treatment response. Drug Alcohol Depend 2016;158:126-131. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698104/
• Robabeh S, Jafar MM, Sharareh H, et al. The effect of cognitive behavior therapy in insomnia due to methadone maintenenace therapy: a randomized clinical trial. Iran J Med Sci 2015;5:396-403.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567598/
• Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-tern outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163:1905-1917.
Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2017;13:307-380.
https://jcsm.aasm.org/doi/10.5664/jcsm.6470
• Saunders EC, McGovern MP, Lambert-Harris C, et al. The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders. Am J Addict 2015;24:722-731. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866634/
• Schiff M, Nacasch N, Levit S, et al. Prolonged exposure for treating PTSD among female methadone patients who were survivors of sexual abuse in Israel. Soc Work Health Care 2015;54:687-707. Abstract only at https://pubmed.ncbi.nlm.nih.gov/26399489/
• Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008;4:487-504. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2576317/
• Seal KH, Maguen SH, Bertenthal D, et al. Observational evidence for buprenorphine’s impact on posttraumatic stress symptoms in veterans with chronic pain and opioid use disorder. J Clin Psychiatry 2016;77:1182-1188.
Abstract only at https://pubmed.ncbi.nlm.nih.gov/27035058/
• Seyffert M, Lagisetty P, Landgraf J, et al. Internet-delivered cognitive behavioral therapy to treat insomnia: a systematic review and meta-analysis. PLoS One 2016; 11(2):e0149139. doi: 10.1371/journal.pone.0149139.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750912/
• Smith MT, Perlis ML, Park BS, et al. Comparative meta-analysis pf pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2—2;159:5-11.
• Tang NKY, Lereya ST, Boulton H, et al. Nonpharmacological treatments of insomnia for long-term painful conditions: a systematic review and meta-analysis of patient-reported outcomes in randomized controlled trials. Sleep 2-15;38:1751-1764. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813361/
• Winkler A, Auer C, Doering BK, et al. Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials. CNS Drugs 2014;28:799-816. Abstract only at https://pubmed.ncbi.nlm.nih.gov/25168785/
• Wu JQ, Appleman ER, Salazar RD, et al. Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: a meta-analysis. JAMA Intern Med 2015;175:1461-1472.
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2363024